gefitinib has been researched along with allobetulinol in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (allobetulinol) | Trials (allobetulinol) | Recent Studies (post-2010) (allobetulinol) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 7 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehaen, W; Li, Y; Wang, R | 1 |
1 other study(ies) available for gefitinib and allobetulinol
| Article | Year |
|---|---|
Antiproliferative effect of mitochondria-targeting allobetulin 1,2,3-triazolium salt derivatives and their mechanism of inducing apoptosis of cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Reactive Oxygen Species; Triazoles | 2020 |